I-MAB

-$1.29 (-1.99%) Today
+$0.90 (+1.42%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell I-MAB and other stocks, options, and ETFs commission-free!

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company. It engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders.

CEO
Hua Qiong Shen
Employees
228
Headquarters
Pudong, Shanghai
Founded
2016

IMAB Key Statistics

Market Cap
4.32B
Price-Earnings Ratio
55.33
Dividend Yield
—
Average Volume
462.62K
High Today
$67.90
Low Today
$63.16
Open Price
$64.74
Volume
507.78K
52 Week High
$67.90
52 Week Low
$18.60

IMAB Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 1, Pre-Market

You May Also Like

REIT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure